| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| Cost of Revenue | $0 | -100.0% |
| R&D Expense | $20.6M | +12.4% |
| SG&A Expense | $12.7M | -11.8% |
| Operating Income | -$45.6M | +14.8% |
| Interest Expense | $18.5M | -0.1% |
| Pre-tax Income | -$55.0M | +9.5% |
| Income Tax | $0 | — |
| Net Income | -$55.0M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $106.2M | -25.2% |
| Accounts Receivable | $0 | -100.0% |
| Inventory | $1.8M | -34.7% |
| Current Assets | $113.6M | -25.5% |
| Total Assets | $201.7M | -19.0% |
| Current Liabilities | $11.7M | -2.4% |
| Long-term Debt | $144.9M | +7.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$41.4M | -18.9% |
| Capital Expenditures | $1.1M | +12.5% |
| Investing Cash Flow | -$507K | -106.1% |
| Financing Cash Flow | -$1.5M | -100.9% |
| Free Cash Flow | -$42.5M | -18.7% |
| +9.5% |
| EPS (Basic) | -$2.61 | -625.0% |
| EPS (Diluted) | -$2.61 | -625.0% |
| Total Liabilities |
| $189.0M |
| +1.8% |
| Stockholders' Equity | $12.7M | -80.0% |